| Bioactivity | AS2690168 freebase is an orally active RANKL signal transduction inhibitor which suppresses RANKL-induced osteoclastogenesis of RAW264 cells. AS2690168 can be utilized in research related to pathological osteolysis[1]. |
| CAS | 1393999-78-4 |
| Formula | C17H13F3N4O |
| Molar Mass | 346.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Morikawa N, et al. Pharmacological characterization of AS2690168, a novel small molecule RANKL signal transduction inhibitor. Eur J Pharmacol. 2022 Jun 5;924:174941. |
AS2690168 (freebase)
CAS: 1393999-78-4 F: C17H13F3N4O W: 346.31
AS2690168 freebase is an orally active RANKL signal transduction inhibitor which suppresses RANKL-induced osteoclastogen
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.